Genmab A (GMAB) Gross Profit: 2018-2024
Historic Gross Profit for Genmab A (GMAB) over the last 7 years, with Dec 2024 value amounting to -$1.4 billion.
- Genmab A's Gross Profit rose 366933436.58% to $337.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was $337.9 million, marking a year-over-year increase of 206.79%. This contributed to the annual value of -$1.4 billion for FY2024, which is 616.98% down from last year.
- Genmab A's Gross Profit amounted to -$1.4 billion in FY2024, which was down 616.98% from -$200.6 million recorded in FY2023.
- Over the past 5 years, Genmab A's Gross Profit peaked at $1.2 billion during FY2020, and registered a low of -$1.4 billion during FY2024.
- In the last 3 years, Genmab A's Gross Profit had a median value of -$346.9 million in 2022 and averaged -$662.0 million.
- Per our database at Business Quant, Genmab A's Gross Profit spiked by 110.49% in 2020 and then plummeted by 616.98% in 2024.
- Over the past 5 years, Genmab A's Gross Profit (Yearly) stood at $1.2 billion in 2020, then crashed by 112.17% to -$143.0 million in 2021, then slumped by 142.64% to -$346.9 million in 2022, then spiked by 42.16% to -$200.6 million in 2023, then crashed by 616.98% to -$1.4 billion in 2024.